| Application no. and date | 18204152.5 (espacenet) (Federated) (European Patent Register), 20111206 | | Patent/reg. no. and date | DK/EP 3461847, 20200923 | | Publication date | 20190403 | | Priority no. and date | US 42029110 P, 20101206, US 201161446990 P, 20110225 | | EP pub. no. and date |
EP 3461847 20190403 | | Effective date | | | Applicant/owner | Seagen Inc., 21823 30th Drive, S.E.
Bothell, WA 98021, US | | Applicant ref. no. | V51191DK00 | | Inventor | SUSSMAN, Django, 21823 30th Drive, S.E.
Bothell, WA 98021, US,
ARTHUR, William, 21823 30th Drive, S.E.
Bothell, WA 98021, US,
NESTEROVA, Albina, 21823 30th Drive, S.E.
Bothell, WA 98021, US,
SMITH, Maria Leia, 13747 Palatine Ave. N
Seattle
WA 98133, US | | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | | Opponent | | | IPC Class | A61K 39/395 (2006.01) , A61K 47/68 (2017.01) , A61P 35/00 (2006.01) , C07K 16/28 (2006.01) | | Title | Humaniserede antistoffer mod LIV-1 og anvendelse heraf til behandling af cancer | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
